ARROWHEAD PHARMACEUT

ARWR
Delayed Quote. Delayed  - 06/18 04:00:00 pm
85.64USD -0.40%
Upcoming events on ARROWHEAD PHARMACEUTICALS, INC.
06/22/21 LifeSci Partners Genetic Medicines Summit
06/23/21 | 02:00am International Liver Congress
06/25/21 FSHD Society International Research Congress
06/25/21 | 09:15am International Liver Congress

Past events on ARROWHEAD PHARMACEUTICALS, INC.
06/17/21Virtual Dana-Farber Harvard Cancer Center Symposium
06/12/21Virtual Alpha-1 National Conference
06/10/21 | 02:10pmGoldman Sachs Global Healthcare Conference
06/03/21 | 02:30pmJefferies Healthcare Conference

Upcoming sector events for ARROWHEAD PHARMACEUTICALS, INC.
06/21/21 | 04:00am BIONTECH SE : SVB Leerink CybeRx Series Vaccine Forum
06/22/21 | 08:00am BIONTECH SE : Annual General Meeting
06/22/21 | 08:00am REGENERON PHARMACEUTICALS : BMO Biopharma Day
07/28/21 GILEAD SCIENCES, INC. : Interim 2021 Earnings Release (Projected)

Past sector events for ARROWHEAD PHARMACEUTICALS, INC.
06/11/21 | 10:30amREGENERON PHARMACEUTICALS : Annual General Meeting
06/11/21 | 03:00amVERTEX PHARMACEUTICALS : European Hematology Association Congress - Abstract #EP736
06/11/21 | 03:00amVERTEX PHARMACEUTICALS : European Hematology Association Congress - Abstract #EP733
06/10/21 | 04:30pmVERTEX PHARMACEUTICALS INCORPORATED : VX-864 Phase 2 Study Results Call

Annual results
Previous yearNext Year
Annual results20202021 (e)
Sales
M $
Released
Forecast
Spread
88,0
135
-35%

171
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-87,2
-40,4
-116%

-20,4
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-93,2
-59,8
-56%

-45,6
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-84,6
-42,3
-100%

-70,5
Net income
M $
Released
Forecast
Spread
-84,6
-42,3
-100%

-70,5
EPS
$
Released
Forecast
Spread
-0,84
-0,45
-86%

-0,59
Announcement Date11/23/2020


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2021 Q22021 Q3 (e)
Sales
M $
Released
Forecast
Spread
32,8
39,4
-17%

43,3
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-26,3
-7,30
-260%

-33,8
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-28,2
-14,3
-98%

-12,5
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-26,8
-9,20
-192%

-10,3
Net income
M $
Released
Forecast
Spread
-26,8
-9,20
-192%

-10,3
EPS
$
Released
Forecast
Spread
-0,26
-0,10
-160%

-0,09
Announcement Date05/04/2021

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise